TrialPediatric blood & cancer2015

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.

Lars M Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.